Pulse

Pulse Innovations is a medical device manufacturer based in India, delivering advanced medical technologies designed to enhance healthcare delivery and improve patient outcomes. Their products are tailored for various medical needs in diverse clinical settings. Pulse Innovations, co-founded by Anshul Sharma and Nishant Goel, in 2025 in Bangalore, India, specializes in manufacturing medical devices. The company recently shifted its business strategy to focus on expanding its product portfolio and enhancing its market presence.

In February 2026, Pulse successfully raised USD 4 mn in a Seed funding round led by 3one4Capital Advisors, with contributions from Incubate Fund and Stride Ventures, marking a pivotal moment in its growth trajectory. The founder has a history of engaging in innovative healthcare solutions, although specific information about previous ventures is not available. Pulse Innovations is a pioneering medical device manufacturer that offers a comprehensive portfolio of advanced, dependable, and affordable medical technologies aimed at improving healthcare delivery. Their core product offerings include solutions in infusion therapy, critical care, cardiology, anesthesia and respiratory care, advanced wound management, diagnostics, renal care, and aesthetics.

These products are designed with a patient-centric approach, addressing specific clinical needs and enhancing the efficiency of healthcare professionals in various therapeutic areas. Pulse's innovative solutions are utilized primarily in hospitals, clinics, and healthcare facilities across India and selected international markets, meeting the demands of a diverse clientele that includes healthcare providers and patients seeking effective medical interventions. Pulse generates revenue through the sale of its extensive range of medical devices, which are supplied directly to healthcare institutions. The company's transaction structure predominantly follows a B2B model, where hospitals and clinics place bulk orders for their medical technologies.

These transactions involve direct sales agreements, ensuring that healthcare organizations have access to the latest innovations tailored to their clinical requirements. While specific pricing plans are not disclosed, Pulse's offerings cater to both high-volume healthcare providers and smaller practices, facilitating a scalable approach to medical technology procurement. The company's adherence to eco-friendly practices and commitment to quality further enhance its value proposition in the competitive MedTech landscape. Pulse Innovations plans to leverage the USD 4 mn raised in Seed funding to advance its product development, obtain necessary regulatory approvals, and expand its distribution network across India.

The company is focusing on launching new medical devices designed for critical care and infusion therapy, targeting the Indian market with expectations of release in late 2026. Additionally, Pulse aims to explore opportunities in international markets, enhancing its reach to better serve healthcare providers and patients globally.